Evidence map›Paper›PMID 41557191›Full record

ArticleDalton transactions (Cambridge, England : 2003)2026

Naphthoquinone-derived tridentate Ru(II) and Os(II) organometallics with exceptional cytotoxicity: synthesis, characterization, stability in aqueous solution and biological

Alexander Rosner, Heiko Geisler, Michaela Hejl, Mathias Gradl, Anton A Legin, Alexander Prado-Roller, Michael A Jakupec, Petra Heffeter, Walter Berger, Bernhard K Keppler and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Dalton transactions (Cambridge, England : 2003), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alexander RosnerInstitute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Währinger Str. 42, 1090 Vienna, Austria. wolfgang.kandioller@univie.ac.at.ORCID http://orcid.org/0000-0001-6005-1334
Heiko GeislerInstitute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Währinger Str. 42, 1090 Vienna, Austria. wolfgang.kandioller@univie.ac.at.ORCID http://orcid.org/0000-0002-2536-5861
Michaela HejlInstitute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Währinger Str. 42, 1090 Vienna, Austria. wolfgang.kandioller@univie.ac.at.
Mathias GradlResearch Cluster "Translational Cancer Therapy Research", Währinger Str. 42, 1090 Vienna, Austria.
Anton A LeginInstitute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Währinger Str. 42, 1090 Vienna, Austria. wolfgang.kandioller@univie.ac.at.ORCID http://orcid.org/0000-0002-4088-5769
Alexander Prado-RollerInstitute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Währinger Str. 42, 1090 Vienna, Austria. wolfgang.kandioller@univie.ac.at.
Michael A JakupecInstitute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Währinger Str. 42, 1090 Vienna, Austria. wolfgang.kandioller@univie.ac.at.ORCID http://orcid.org/0000-0001-7945-1426
Petra HeffeterResearch Cluster "Translational Cancer Therapy Research", Währinger Str. 42, 1090 Vienna, Austria.ORCID http://orcid.org/0000-0001-6401-8646
Walter BergerResearch Cluster "Translational Cancer Therapy Research", Währinger Str. 42, 1090 Vienna, Austria.ORCID http://orcid.org/0000-0003-0014-1658
Bernhard K KepplerInstitute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Währinger Str. 42, 1090 Vienna, Austria. wolfgang.kandioller@univie.ac.at.
Wolfgang KandiollerInstitute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Währinger Str. 42, 1090 Vienna, Austria. wolfgang.kandioller@univie.ac.at.ORCID http://orcid.org/0000-0002-5630-712X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, a panel of twelve ruthenium(II) and osmium(II) derived

Indexed as

Antineoplastic AgentsCoordination ComplexesNaphthoquinonesOsmiumRutheniumCell CycleCell Line, TumorCell ProliferationCell SurvivalDrug Screening Assays, AntitumorHumansMolecular StructureSolutionsStructure-Activity RelationshipWaterAntineoplastic AgentsCoordination ComplexesNaphthoquinonesOsmiumRutheniumSolutionsWater

Identifiers

PMID41557191
PMCPMC12818348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.